Skip to search.
 FTSE 100 Up 0.95%

BioCryst Pharmaceuticals, Inc. (BCRX)

-NasdaqGS
14.95 Down 0.26(1.71%) 4 Aug 21:00
Add to Portfolio
Prev Close:15.21
Open:15.25
Bid:15.00 x 200
Ask:15.35 x 100
1y Target Est:17.63
Beta:3.62
Next Earnings Date: 7-Aug-15BCRX Earnings announcement
Day's Range:14.84 - 15.45
52wk Range:7.85 - 16.83
Volume:446,777
Avg Vol (3m):893,997
Market Cap:1.08b
P/E (ttm):N/A
EPS (ttm):-0.72
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BCRXDown 1.71%1.08b
GSKDown 0.14%104.93b
RHHBYDown 0.08%244.62b

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):64.98
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-0.97
Quarterly EPS Est (Jun-15) :-0.22
Mean Recommendation*:1.9
PEG Ratio (5 yr expected):0.68

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BioCryst Pharmaceuticals, Inc., a biotechnology company, designs, optimizes, and develops small molecule drugs that block key enzymes involved in the pathogenesis of diseases. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback